EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER
| dc.contributor.author | Sendur, M. A. | |
| dc.contributor.author | Aksoy, S. | |
| dc.contributor.author | Uncu, D. | |
| dc.contributor.author | Demir, H. | |
| dc.contributor.author | Yuksel, S. | |
| dc.contributor.author | Ekinci, A. S. | |
| dc.contributor.author | Kaplan, A. | |
| dc.date.accessioned | 2024-04-24T17:08:04Z | |
| dc.date.available | 2024-04-24T17:08:04Z | |
| dc.date.issued | 2014 | |
| dc.department | Dicle Üniversitesi | en_US |
| dc.description | 39th ESMO Congress (ESMO) -- SEP 26-30, 2014 -- Madrid, SPAIN | en_US |
| dc.description.abstract | [Abstract Not Available] | en_US |
| dc.description.sponsorship | ESMO | en_US |
| dc.identifier.doi | 10.1093/annonc/mdu327.44 | |
| dc.identifier.issn | 0923-7534 | |
| dc.identifier.issn | 1569-8041 | |
| dc.identifier.uri | https://doi.org/10.1093/annonc/mdu327.44 | |
| dc.identifier.uri | https://hdl.handle.net/11468/17181 | |
| dc.identifier.volume | 25 | en_US |
| dc.identifier.wos | WOS:000346901000167 | |
| dc.identifier.wosquality | Q1 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.language.iso | en | en_US |
| dc.publisher | Oxford Univ Press | en_US |
| dc.relation.ispartof | Annals of Oncology | |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.subject | [No Keyword] | en_US |
| dc.title | EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER | en_US |
| dc.title | EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER | |
| dc.type | Conference Object | en_US |
